Validations: Serialization, Aggregation & Supply-Chain Data Integrity
Damaged Codes: Reprint, Relabel, or Scrap Damaged Codes: Reprint, Relabel, or Scrap In the pharmaceutical industry, the integrity of product identification through serialization and aggregation is paramount for compliance with regulations such as the US Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD). However, damaged or illegible codes on packages create significant challenges. This article…
De-Aggregation Scenarios: Case and Pallet In today’s pharmaceutical supply chain, maintaining data integrity and compliance with regulations such as DSCSA compliance in the United States, and the EU FMD requirements is critical. Effective management of serialization and aggregation processes goes beyond initial implementation; it involves rigorous validation and exception handling during de-aggregation scenarios. This article provides a detailed step-by-step tutorial…
Returns and Reverse Logistics: Serialization Hooks Returns and Reverse Logistics: Serialization Hooks Understanding Serialization and Aggregation in Pharmaceutical Logistics The pharmaceutical industry’s commitment to compliance and safety is encapsulated in its rigorous serialization and aggregation processes. Serialization uniquely identifies each saleable unit of prescription medication, a necessity driven by regulations like the Drug Supply Chain Security Act (DSCSA) in the…
Decommissioning Reasons & Evidence Decommissioning Reasons & Evidence in Serialization and Aggregation In the pharmaceutical and biopharmaceutical industries, serialization and aggregation are pivotal processes aimed at enhancing supply chain integrity and compliance with regulatory mandates such as the Drug Supply Chain Security Act (DSCSA) and European Falsified Medicines Directive (EU FMD). A critical aspect of these processes involves understanding decommissioning…
Suspect/Illegitimate Product Workflows: A Comprehensive Guide Understanding Serialization and its Implications Serialization has emerged as a critical aspect of pharmaceutical supply chain integrity. As part of the Drug Supply Chain Security Act (DSCSA), serialization involves assigning a unique identifier to each saleable unit of prescription products. This process not only facilitates product traceability but also enhances safety, particularly in mitigating…
Top Reconciliation Mistakes—and Fixes Top Reconciliation Mistakes—and Fixes Understanding Reconciliation in the Pharmaceutical Supply Chain In the pharmaceutical industry, reconciliation refers to the process of ensuring that all records and transactions match between different systems, focusing particularly on product serialization and aggregation. This process is critical for maintaining product traceability and integrity, as mandated by the Drug Supply Chain Security…
Periodic Review of Line Configurations The pharmaceutical industry is subject to rigorous regulatory standards that necessitate meticulous qualification of processes, equipment, and systems involved in serialization, aggregation, and supply-chain data integrity. This article provides a comprehensive, step-by-step guide on the periodic review of line configurations within the context of serialization and aggregation programs. Specific attention will be directed toward user…
Exception Taxonomy: What Counts, What Doesn’t The implementation of serialization and aggregation practices in the pharmaceutical industry is no longer optional but a necessity driven by regulatory requirements such as the Drug Supply Chain Security Act (DSCSA) in the United States and the EU Falsified Medicines Directive (FMD) in Europe. To navigate these complex regulations effectively, professionals must understand both…
False Rejects vs Real Errors: Decision Rules for Serialization and Aggregation Understanding Serialization and Aggregation in Pharmaceutical Supply Chains Serialization and aggregation are critical components of pharmaceutical supply chain management, particularly in the context of compliance with regulations like the Drug Supply Chain Security Act (DSCSA) in the US and the EU Falsified Medicines Directive (EU FMD) in the European…
CMO Line Qualification: Evidence Expectations Understanding the CMO Line Qualification Process The Contract Manufacturing Organization (CMO) line qualification process is essential for ensuring that pharmaceutical products are manufactured to the highest quality standards. This process is a vital part of compliance with regulatory expectations set forth by entities such as the US FDA, the EMA, and the MHRA. This section…